Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Sales and Divestitures (2018 - 2025)

Historic Gains from Sales and Divestitures for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $642000.0.

  • Verastem's Gains from Sales and Divestitures rose 71620.2% to $642000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $642000.0, marking a year-over-year increase of 71620.2%. This contributed to the annual value of $468581.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Verastem's Gains from Sales and Divestitures stood at $642000.0, which was up 71620.2% from $591731.0 recorded in Q2 2025.
  • Verastem's 5-year Gains from Sales and Divestitures high stood at $5.3 million for Q4 2022, and its period low was $14279.0 during Q1 2024.
  • For the 5-year period, Verastem's Gains from Sales and Divestitures averaged around $835656.4, with its median value being $171583.0 (2023).
  • As far as peak fluctuations go, Verastem's Gains from Sales and Divestitures crashed by 9375.98% in 2024, and later skyrocketed by 166578.14% in 2025.
  • Over the past 5 years, Verastem's Gains from Sales and Divestitures (Quarter) stood at $5.0 million in 2021, then increased by 5.44% to $5.3 million in 2022, then tumbled by 99.06% to $49815.0 in 2023, then soared by 840.64% to $468581.0 in 2024, then surged by 37.01% to $642000.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $642000.0 for Q3 2025, versus $591731.0 for Q2 2025 and $114342.0 for Q1 2025.